UPDATE 2-Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

NEW YORK, Jan 30 (Reuters) - Three of the biggest makers of

diabetes treatments, Sanofi SA, Novo Nordisk

and Eli Lilly & Co, were named in a proposed

class action lawsuit by a group of patients alleging

price-fixing.

Read more